Literature DB >> 18793189

Key issues in F2-isoprostane analysis.

Jaffar Nourooz-Zadeh1.   

Abstract

A large body of evidence indicates that measurement of F2-isoprostanes, specific prostaglandin F2-like compounds derived from the non-enzymatic peroxidation of arachidonic acid, is a reliable biomarker of oxidant stress in the human body. Since the discovery of F2-isoprostanes in the early 1990s, a variety of analytical approaches has been introduced for the quantification of these novel compounds. The aim of the present review is to shed light on the available gas chromatographic-mass spectrometric assays for the measurement of plasma or urinary F2-isoprostanes and to highlight a number of issues which need to be addressed in order to implement F2-isoprostane measurement as a gold-standard biomarker of oxidative stress in biological samples.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18793189     DOI: 10.1042/BST0361060

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  17 in total

1.  Temporal sequence of major biochemical events during blood bank storage of packed red blood cells.

Authors:  Brad S Karon; Camille M van Buskirk; Elizabeth A Jaben; James D Hoyer; David D Thomas
Journal:  Blood Transfus       Date:  2012-03-28       Impact factor: 3.443

Review 2.  Urinary biomarkers of oxidative status.

Authors:  Dora Il'yasova; Peter Scarbrough; Ivan Spasojevic
Journal:  Clin Chim Acta       Date:  2012-06-07       Impact factor: 3.786

3.  Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L:-carnitine supplementation.

Authors:  Graziela S Ribas; Giovana B Biancini; Caroline Mescka; Carlos Y Wayhs; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-07-22       Impact factor: 5.046

4.  Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil.

Authors:  Claudio De Felice; Cinzia Signorini; Thierry Durand; Lucia Ciccoli; Silvia Leoncini; Maurizio D'Esposito; Stefania Filosa; Camille Oger; Alexandre Guy; Valérie Bultel-Poncé; Jean-Marie Galano; Alessandra Pecorelli; Laura De Felice; Giuseppe Valacchi; Joussef Hayek
Journal:  Genes Nutr       Date:  2012-03-08       Impact factor: 5.523

5.  Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress.

Authors:  Kristin A Guertin; Rachael K Grant; Kathryn B Arnold; Lindsay Burwell; JoAnn Hartline; Phyllis J Goodman; Lori M Minasian; Scott M Lippman; Eric Klein; Patricia A Cassano
Journal:  Free Radic Biol Med       Date:  2016-03-22       Impact factor: 7.376

6.  Urinary concentration of 8-isoprostane as marker of severity of pediatric OSAS.

Authors:  Maria Pia Villa; Maria Chiara Supino; Susanna Fedeli; Jole Rabasco; Ottavio Vitelli; Marco Del Pozzo; Giovanna Gentile; Luana Lionetto; Mario Barreto; Maurizio Simmaco
Journal:  Sleep Breath       Date:  2014-01-17       Impact factor: 2.816

7.  Profiling of oxidative stress in patients with inborn errors of metabolism.

Authors:  Peter J Mc Guire; Aditya Parikh; George A Diaz
Journal:  Mol Genet Metab       Date:  2009-06-14       Impact factor: 4.797

8.  Increased oxidative stress in patients with depression and its relationship to treatment.

Authors:  Cecilia P Chung; Dennis Schmidt; Charles Michael Stein; Jason D Morrow; Ronald M Salomon
Journal:  Psychiatry Res       Date:  2012-12-11       Impact factor: 3.222

9.  Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method.

Authors:  Wei Liu; Jason D Morrow; Huiyong Yin
Journal:  Free Radic Biol Med       Date:  2009-07-30       Impact factor: 7.376

10.  Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease.

Authors:  Sonia Chalbot; Henrik Zetterberg; Kaj Blennow; Tormod Fladby; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Clin Chem       Date:  2009-10-22       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.